326 related articles for article (PubMed ID: 8225608)
1. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
[TBL] [Abstract][Full Text] [Related]
2. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
Heath PT
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
Englund JA; Glezen WP; Thompson C; Anwaruddin R; Turner CS; Siber GR
Pediatr Infect Dis J; 1997 Dec; 16(12):1122-30. PubMed ID: 9427456
[TBL] [Abstract][Full Text] [Related]
4. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH
Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176
[TBL] [Abstract][Full Text] [Related]
6. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
7. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
[TBL] [Abstract][Full Text] [Related]
8. The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants.
Chung GH; Kim KH; Daum RS; Insel RA; Siber GR; Sood S; Gupta RK; Marchant C; Nahm MH
Infect Immun; 1995 Nov; 63(11):4219-23. PubMed ID: 7591050
[TBL] [Abstract][Full Text] [Related]
9. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
Massó F; Paéz A; Arista A; Salmón L; Montaño L
Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
[TBL] [Abstract][Full Text] [Related]
10. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
[TBL] [Abstract][Full Text] [Related]
12. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
14. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
15. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
[TBL] [Abstract][Full Text] [Related]
16. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
[TBL] [Abstract][Full Text] [Related]
17. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine.
Reid R; Santosham M; Croll J; Thompson C; Newcomer W; Siber GR
Pediatr Infect Dis J; 1993 Oct; 12(10):812-5. PubMed ID: 8284116
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
Bulkow LR; Wainwright RB; Letson GW; Chang SJ; Ward JI
Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of Haemophilus influenzae type B vaccines in children with hepatoportoenterostomies.
Rosenthal P; Wong V; Ross LA; Kim KS
J Pediatr Gastroenterol Nutr; 1990 Aug; 11(2):201-4. PubMed ID: 2395059
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy.
Peltola H; Eskola J; Käyhty H; Takala AK; Mäkelä PH
Arch Pediatr Adolesc Med; 1994 Jun; 148(6):620-5. PubMed ID: 8193690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
